Leo Wealth LLC’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$705K Buy
8,805
+293
+3% +$24.2K 0.05% 223
2025
Q4
$726K Sell
8,512
-4,060
-32% -$333K 0.05% 214
2025
Q3
$978K Sell
12,572
-97
-0.8% -$7.58K 0.13% 130
2025
Q2
$991K Buy
12,669
+181
+1% +$13.5K 0.08% 174
2025
Q1
$905K Buy
12,488
+150
+1% +$10.7K 0.13% 132
2024
Q4
$913K Sell
12,338
-68
-0.5% -$4.76K 0.08% 164
2024
Q3
$819K Sell
12,406
-91
-0.7% -$6.61K 0.07% 175
2024
Q2
$1.15M Buy
+12,497
New +$1.11M 0.12% 130

Other funds holding EW

Leo Wealth LLC's EW Position: Q1 2026 in Review

Leo Wealth LLC increased its Edwards Lifesciences (EW) stake by 3.4% in Q1 2026, buying an estimated $24.2K and bringing the position to 8,805 shares worth $705K. The position accounts for 0.05% of the portfolio, ranked #223.

Leo Wealth LLC first reported a position in EW in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.15M in Q2 2024. 1,288 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Leo Wealth LLC held 8,805 shares of Edwards Lifesciences worth $705K as of Q1 2026.
  • Leo Wealth LLC bought 293 Edwards Lifesciences shares in Q1 2026, an estimated $24.2K.
  • Edwards Lifesciences made up 0.05% of Leo Wealth LLC's portfolio in Q1 2026, its #223 holding.
  • Leo Wealth LLC first reported a position in Edwards Lifesciences in Q2 2024 and has held it in 8 quarters since.
  • Leo Wealth LLC's Edwards Lifesciences position peaked at $1.15M in Q2 2024.
  • 1,288 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Leo Wealth LLC's 13F filing for Q1 2026, filed 5 May 2026.